Economic costs of full-blown and subthreshold panic disorder

被引:83
作者
Batelaan, Neeltje
Smit, Filip
de Graaf, Ron
van Balkom, Anton
Vollebergh, Wilma
Beekman, Aartjan
机构
[1] Netherlands Inst Mental Hlth & Addict, NL-3500 AS Utrecht, Netherlands
[2] Vrije Univ Amsterdam Med Ctr, Dept Psychiat, Amsterdam, Netherlands
[3] Vrije Univ Amsterdam Med Ctr, Inst Res Extramural Med, Amsterdam, Netherlands
[4] Vrije Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands
[5] Univ Utrecht, Dept Social Sci, Utrecht, Netherlands
关键词
agoraphobia; comorbidity; epidemiology; health expenditures; panic disorder;
D O I
10.1016/j.jad.2007.03.013
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Data on the societal costs of mental disorders are necessary to inform health policies. Methods: This study assessed the costs of panic disorder and subthreshold panic disorder, compared these with costs of other mental disorders, and assessed the effects of (psychiatric and somatic) comorbidity and agoraphobia on the costs of panic. Using a large, population-based study in The Netherlands (n=5504), both medical and production costs were estimated from a societal perspective within a one-year timeframe. Results: Annual per capita costs of panic disorder were C 10,269, while subthreshold panic disorder generated (sic)6384. These costs were higher than those of the other mental disorders studied. About one quarter of the costs could be attributed to comorbidity. Agoraphobia was associated with higher costs. Limitations: Methodological choices influence cost estimates. In the present study most of these will result in conservative cost estimates. Conclusions: Panic thus causes substantial societal costs. Given the availability of effective treatment, treatment may not only benefit individual patients, but also have economic returns for society. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:127 / 136
页数:10
相关论文
共 57 条
  • [1] Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P38
  • [2] Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P28
  • [3] Cost of anxiety disorders in Europe
    Andlin-Sobcki, P
    Wittchen, HU
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 : 39 - 44
  • [4] Cost of addiction in Europe
    Andlin-Sobocki, P
    Rehm, J
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 : 28 - 33
  • [5] Cost of affective disorders in Europe
    Andlin-Sobocki, P
    Wittchen, HU
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 : 34 - 38
  • [6] Utilising survey data to inform public policy: Comparison of the cost-effectiveness of treatment of ten mental disorders
    Andrews, G
    Issakidis, C
    Sanderson, K
    Corry, J
    Lapsley, H
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 2004, 184 : 526 - 533
  • [7] [Anonymous], DSMIIIR AM PSYCH ASS
  • [8] SSRIs vs. TCAs in the treatment of panic disorder: a meta-analysis
    Bakker, A
    van Balkom, AJLM
    Spinhoven, P
    [J]. ACTA PSYCHIATRICA SCANDINAVICA, 2002, 106 (03) : 163 - 167
  • [9] Thresholds for health and thresholds for illness:: panic disorder versus subthreshold panic disorder
    Batelaan, Neeltje
    De Graaf, Ron
    Van Balkom, Anton
    Vollebergh, Wilma
    Beekman, Aartjan
    [J]. PSYCHOLOGICAL MEDICINE, 2007, 37 (02) : 247 - 256
  • [10] The Netherlands Mental Health Survey and Incidence Study (NEMESIS): objectives and design
    Bijl, RV
    van Zessen, G
    Ravelli, A
    de Rijk, C
    Langendoen, Y
    [J]. SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY, 1998, 33 (12) : 581 - 586